Is optimal first-line chemotherapy deliverable in all newly diagnosed ovarian cancers? A population-based study

NICE guidance recommends the use of paclitaxel and a platinum therapy for all cases of ovarian cancer. We report our experience of treating 133 patients with ovarian cancer over a 3-year period. Where indicated, 91% received chemotherapy. A taxane/platinum combination was found to be appropriate in...

Descripción completa

Detalles Bibliográficos
Autores principales: McNally, O M, Delaney, E, Petty, R D, Cruickshank, M E, Hutcheon, A W, Parkin, D E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376968/
https://www.ncbi.nlm.nih.gov/pubmed/12966409
http://dx.doi.org/10.1038/sj.bjc.6601071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376968/
https://www.ncbi.nlm.nih.gov/pubmed/12966409
http://dx.doi.org/10.1038/sj.bjc.6601071

Ejemplares similares